{"DataElement":{"publicId":"3474989","version":"1","preferredName":"Gynecologic Vaginal Tumor Federation of Gynecology and Obstetrics (FIGO) 2009 Stage","preferredDefinition":"Anatomic extent of the primary carcinoma of the vagina based on surgical pathologic examination.","longName":"3474945v1.0:3474966v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3474945","version":"1","preferredName":"Gynecologic Neoplasm Vagina Stage","preferredDefinition":"Of or relating to or practicing gynecology; pertaining to the health issues of women._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._The female genital canal, extending from the uterus to the vulva._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"2206690v1.0:3474943v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2206690","version":"1","preferredName":"Gynecologic Neoplasm","preferredDefinition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C28016:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gynecologic","conceptCode":"C28016","definition":"Of or relating to or practicing gynecology; pertaining to the health issues of women.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0016-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3474943","version":"1","preferredName":"Vagina Stage","preferredDefinition":"The female genital canal, extending from the uterus to the vulva.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C12407:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vagina","conceptCode":"C12407","definition":"The female genital canal, extending from the uterus to the vulva.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BDB14A-1B02-57D2-E040-BB89AD437301","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BDB14A-1B13-57D2-E040-BB89AD437301","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per request by D.Reeves. mc 6/5/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3474966","version":"1","preferredName":"Vaginal Carcinoma Federation of Gynecology and Obstetrics (FIGO) 2009 Stage","preferredDefinition":"A carcinoma arising from the vaginal epithelium. The majority of vaginal carcinomas are squamous cell carcinomas._An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology. They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies._A number with no fractional part, including the negative and positive numbers as well as zero.::2009_The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3474966v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IVB","valueDescription":"Vaginal Cancer pM1 TNM Finding v7","ValueMeaning":{"publicId":"3449337","version":"1","preferredName":"Vaginal Cancer pM1 TNM Finding v7","longName":"3449337","preferredDefinition":"Vaginal cancer with distant metastasis.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal Cancer pM1 TNM Finding v7","conceptCode":"C89471","definition":"Vaginal cancer with distant metastasis.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF2A2EDD-B39F-258B-E040-BB89AD430670","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEC699-3D8C-9F9F-E040-BB89AD430971","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"IVA","valueDescription":"Vaginal Cancer pT4 TNM Finding v7","ValueMeaning":{"publicId":"3449313","version":"1","preferredName":"Vaginal Cancer pT4 TNM Finding v7","longName":"3449313","preferredDefinition":"Vaginal cancer invading the mucosa of the bladder or rectum and/or extending beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4) .  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal Cancer pT4 TNM Finding v7","conceptCode":"C89465","definition":"Vaginal cancer invading the mucosa of the bladder or rectum and/or extending beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4).  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF2A2EDD-B1AD-258B-E040-BB89AD430670","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEC699-3DA0-9F9F-E040-BB89AD430971","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"I","valueDescription":"Vaginal Cancer pT1 TNM Finding v7","ValueMeaning":{"publicId":"3449307","version":"1","preferredName":"Vaginal Cancer pT1 TNM Finding v7","longName":"3449307","preferredDefinition":"Vaginal cancer with a tumor confined to vagina. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal Cancer pT1 TNM Finding v7","conceptCode":"C89462","definition":"Vaginal cancer with a tumor confined to vagina. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF2A2EDD-B13B-258B-E040-BB89AD430670","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEC699-3DB4-9F9F-E040-BB89AD430971","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"II","valueDescription":"Vaginal Cancer pT2 TNM Finding v7","ValueMeaning":{"publicId":"3449309","version":"1","preferredName":"Vaginal Cancer pT2 TNM Finding v7","longName":"3449309","preferredDefinition":"Vaginal cancer invading the paravaginal tissues but not the pelvic wall. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal Cancer pT2 TNM Finding v7","conceptCode":"C89463","definition":"Vaginal cancer invading the paravaginal tissues but not the pelvic wall. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF2A2EDD-B161-258B-E040-BB89AD430670","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEC699-3DC8-9F9F-E040-BB89AD430971","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"},{"value":"III","valueDescription":"Vaginal Cancer pT3 TNM Finding v7","ValueMeaning":{"publicId":"3449311","version":"1","preferredName":"Vaginal Cancer pT3 TNM Finding v7","longName":"3449311","preferredDefinition":"Vaginal cancer extending to the pelvic wall.  Pelvic wall is defined as muscle, fascia, neurovascular structures, or skeletal portions of the bony pelvis.  (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal Cancer pT3 TNM Finding v7","conceptCode":"C89464","definition":"Vaginal cancer extending to the pelvic wall.  Pelvic wall is defined as muscle, fascia, neurovascular structures, or skeletal portions of the bony pelvis.  (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF2A2EDD-B187-258B-E040-BB89AD430670","latestVersionIndicator":"Yes","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1BEC699-3DDC-9F9F-E040-BB89AD430971","beginDate":"2012-05-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3474965","version":"1","preferredName":"Vaginal Carcinoma Federation of Gynecology and Obstetrics Integer::2009 Stage","preferredDefinition":"A carcinoma arising from the vaginal epithelium. The majority of vaginal carcinomas are squamous cell carcinomas.:An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology.  They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies.:A number with no fractional part, including the negative and positive numbers as well as zero.::2009:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3474965v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal Carcinoma","conceptCode":"C3917","definition":"A carcinoma arising from the vaginal epithelium. The majority of vaginal carcinomas are squamous cell carcinomas.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Federation of Gynecology and Obstetrics","conceptCode":"C89808","definition":"An international organization with a mission to promote the wellbeing of women and to raise the standards of practice in obstetrics and gynecology. They are the creator of staging criteria to describe the extent and spread of gynecologic malignancies.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BEC699-3D59-9F9F-E040-BB89AD430971","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"ONEDATA","dateModified":"2012-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BEC699-3D6A-9F9F-E040-BB89AD430971","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"COOPERM","dateModified":"2012-06-05","changeDescription":"Created for CRF standard harmonization. Released per request by D.Reeves. mc 6/5/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3447901","version":"1","longName":"Vagina","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000586","version":"1","longName":"FIGO","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"},{"publicId":"10000585","version":"1","longName":"FIGO","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"FIGO Stage","type":"Preferred Question Text","description":"FIGO Stage","url":null,"context":"NCI Standards"}],"origin":"FIGO:International Federal of Gynecology and Obstetrics","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"C1BEC699-413D-9F9F-E040-BB89AD430971","latestVersionIndicator":"Yes","beginDate":"2012-06-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-05","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per request by D.Reeves. mc 6/5/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}